Yukihiro Hamada, Pharm D

Associate Director
Tokyo Women's Medical University, Japan

Disclosure(s): No financial relationships to disclose

Poster(s):

• 658 - Evaluation of Effectiveness of Cefmetazole vs Meropenem for Invasive Urinary Tract Infections Caused by ESBL-Producing Escherichia coli: A Prospective Multicenter Observational Study
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET